Jaguar Animal Health

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$2,979
$2,171
$3,509
$3,108
Gross Profit
2,452
1,699
2,952
2,567
EBITDA
-7,451
-9,421
-15,753
-6,666
EBIT
-8,007
-9,967
-16,346
-7,262
Net Income
-10,407
-10,464
-9,920
-9,854
Net Change In Cash
2,979
2,171
3,509
3,108
Free Cash Flow
-6,193
-7,316
-8,041
-6,325
Cash
2,207
5,690
8,002
13,269
Basic Shares
1,014
626
313
374

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$11,689
$9,761
$11,956
$4,335
Gross Profit
9,734
7,724
9,937
2,002
EBITDA
-36,662
-33,131
-33,380
-42,352
EBIT
-39,020
-34,291
-35,672
-44,179
Net Income
-38,492
-41,300
-47,454
-60,251
Net Change In Cash
11,689
9,761
11,956
4,335
Free Cash Flow
-29,615
-33,242
-34,779
-34,976
Cash
8,002
6,469
5,469
17,051
Basic Shares
294
15

Earnings Calls

Quarter EPS
2025-06-30
-$10.26
2025-03-31
-$18.77
2024-12-31
-$125.80
2024-09-30
-$1.05